Abstract
AbstractTo bridge the gap between organ demand and supply, xenotransplantation has long been considered as a realistic option for end-stage organ failure. Early this year this promise became reality for David Bennett Sr., the first patient whose own failing heart was replaced with a xeno-pig heart. To get here has been a rollercoaster ride of physiological hurdles seemingly impossible to overcome, technological breakthroughs and ethical and safety concerns. It started in 1984, with Stephanie Fae Beauclair, also known as baby Fae, receiving a baboon heart, which allowed her to survive for another 30 days. For ethical reasons primate work was soon abandoned in favour of the pig. But increased phylogenetic distance also brought with it an increased immunological incompatibility. It has been the development of ever more sophisticated genetic engineering tools, which brought down the physiological barriers, enabled humanisation of porcine organs and helped addressing safety concerns. This renewed the confidence in xenotransplantation, brought new funding opportunities and resulted finally in the first in human trial.
Funder
Deutsche Forschungsgemeinschaft
Technische Universität München
Publisher
Springer Science and Business Media LLC
Subject
Agronomy and Crop Science,Genetics,Animal Science and Zoology,Biotechnology
Reference55 articles.
1. Abicht J, Mayr T, Fischer K, Reichart B, Niemann H, Panelli A, Guethoff S, Brenner P and Schnieke A (2016) Ex vivo testing of new genetical modifications for cardiac xenotransplantation. J Heart Lung Transplant 35(4):S186–S187
2. Adams AB, Kim SC, Martens GR, Ladowski JM, Estrada JL, Reyes LM, Breeden C, Stephenson A, Eckhoff DE, Tector M, Tector AJ (2018) Xenoantigen deletion and chemical immunosuppression can prolong renal xenograft survival. Ann Surg 268(4):564–573. https://doi.org/10.1097/SLA.0000000000002977
3. Ahrens HE, Petersen B, Ramackers W, Petkov S, Herrmann D, Hauschild-Quintern J, Lucas-Hahn A, Hassel P, Ziegler M, Baars W, Bergmann S, Schwinzer R, Winkler M, Niemann H (2015) Kidneys from α1,3-galactosyltransferase knockout/human heme oxygenase-1/human A20 transgenic pigs are protected from rejection during ex vivo perfusion with human blood. Transplant Direct 1(6):e23. https://doi.org/10.1097/txd.0000000000000533
4. Badin RA, Vanhove B, Vadori M, Fante F, Boldrin M, DeBenedictis GM, Cavicchioli L, Sgarabotto D, Jan C and Daguin V (2013). Systemic immunosuppression plus local production of CTLA4-Ig to control rejection of transgenic pig neuroblasts in non-human primates. Joint congress of IXA and organ transplantation in ABO-incompatible and hyperimmunized recipients (IXA 2013), Wiley-Blackwell.
5. Bottino R, Knoll MF, Graeme-Wilson J, Klein EC, Ayares D, Trucco M, Cooper DKC (2017) Safe use of anti-CD154 monoclonal antibody in pig islet xenotransplantation in monkeys. Xenotransplantation. https://doi.org/10.1111/xen.12283
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献